Novel therapeutic strategy for refractory and relapse childhood acute leukemia
Ended Project Grant Awarded Last action
- Award ID
- R43CA171344
- Recipient
-
Apex Therapeutics, Inc. UEI V9F1G49CLG95
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $240,322
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Place of performance
- Indianapolis, IN 46204, USA
Award details come from USAspending.gov.
Quick answers
Who received award R43CA171344?
R43CA171344 was awarded to Apex Therapeutics, Inc. by National Institutes of Health (Department of Health and Human Services) on July 1, 2013.
How much is award R43CA171344 worth?
$240,322 has been obligated on R43CA171344.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award